Unique in vivo model in immuno-oncology for assessing efficacy of antibodies

AIS 2020


Download the poster :

What kind of compounds are you developing?*

Which in vivo model are you using for in vivo preclinical efficacy evaluation?*

What do you see as the major bottlenecks with your current in vivo model?*

* Fields required

By checking this box, I accept the privacy policy of this site.Learn more